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Metacognitive Interpersonal Therapy in group (MIT-G) for young adults with personality 
disorders: a pilot randomized controlled trial. 
 
Abstract 
Young  adults with personality disorders (PD) other than borderline are in urgent need of 
validated treatments to help them in managing important life transitions. Therapeutic interventions 
focused upon social and interpersonal difficulties may facilitate these individuals in maximising 
opportunities for employment, forming stable romantic relationships and belong to social groups. It 
is also important that they are offered evidence-based, first-line time-limited treatments in order to 
maximize effectiveness and reduce costs. We developed a 16-session programme of group-based 
Metacognitive Interpersonal Therapy (MIT-G) including psychoeducation on the main interpersonal 
motives, an experiential component enabling practice of awareness of mental states; and use of 
mentalistic knowledge for purposeful problem-solving. We report a feasibility, acceptability and 
clinical significance Randomized Clinical Trial. Participants meeting inclusion criteria were 
randomized to receive MIT-G (n=10) or waiting list+TAU (n=10). Drop-out rate was low, and session 
attendance high (92.19%). Participants in the MIT-G arm had symptomatic and functional 
improvements consistent with large effect sizes. In the MIT-G arm similarly large effects were noted 
for increased capacity to understand mental states and regulate social interactions using mentalistic 
knowledge. Results were sustained at follow-up. Our findings suggest potential for applying MIT-G 
in larger samples to further test its effectiveness in reducing PD-related symptoms and problematic 
social functioning.   
 
 
 
 
 
Introduction 
 
Evidence for the effectiveness of psychotherapy for individuals with personality disorders 
(PD) is accumulating, challenging the belief that PDs are treatment-resistant (Livesley, Dimaggio & 
Clarkin, 2016). This evidence notwithstanding, there are several issues that require addressing. First, 
with some notable exceptions (e.g. Bamelis et al., 2014), the large majority of the studies are focused 
on borderline PDs (e.g. Bateman & Fonagy, 2009; McMain et al., 2009), leaving other PDs under-
investigated. Indeed, there is an urgent need for evidence-based psychological interventions (EBPI’s) 
addressing the needs of patients with a wide range of PDs (e.g. obsessive- paranoid, dependent, 
narcissistic, avoidant).  
A second problem is treatment costs. Therapy for PD requires time, as even well designed, 
successful trials of EBPIs (e.g. Bateman & Fonagy, 2009; Doering et al., 2010; Jørgensen et al., 2013;  
McMain et al., 2009) are compromised by significant proportions of non-responders, and high levels 
of post-treatment morbidity. With increased pressure on resources for healthcare delivery, clinicians 
face the conundrum of optimize therapeutic effectiveness whilst also maximizing economies in 
delivery time (Kramer et al., 2014). The challenge of increasing effectiveness can be particularly 
pronounced for young adults with PD, as they face life transitions such as job instability, moving 
outside their home town, formation of stable romantic bonds and affiliating with new social groups. 
These life challenges differ from earlier, adolescent difficulties in social and interpersonal 
functioning. Obtaining rapid therapeutic outcomes with these individuals may facilitate more 
effective life transitions, thus helping them move forward in life, whilst also forestalling further loss 
of opportunities and preventing the emergence of chronicity in PD.  
One promising format for EBPI’s is a group-based approach. First, group therapy has 
economic advantage via cost savings. Second, for young adults, it may be particularly beneficial, as 
it provides a ‘safe’, boundaried and protected arena for modelling social interaction. This  enables 
therapeutic scaffolding of behavior change towards more challenging real-life interactions – either 
through work, interactions with peers or with potential romantic partners. From an early intervention 
perspective, group psychotherapy has demonstrated effectiveness in a 1-year programme for 
teenagers with emergent Borderline PD (Bo et al., 2016). A challenge for clinicians is therefore to 
design therapies that can lead to rapid outcomes which boost individuals’ capacities to engage in a 
fulfilling and adapted social life.  
Following these principles for delivery of EBPI’s, we developed a treatment protocol tailored 
to maximize outcomes, guided by two theoretical underpinnings – interpersonal motives in social 
context and metacognition. Next, we briefly describe the theoretical background which led us to 
design a programme designed to help participants learn the basis of human motivation in social 
context and practice their metacognitive abilities. 
  
Interpersonal Motives in social context 
Humans often struggle to meet goals related to basic evolutionarily shaped motives and suffer 
if they foresee that these goals will stay unmet (Bowlby, 1969; Fassone et al., 2016; ; Gilbert, 1989; 
Ivaldi, 2016; Lichtenberg et al.,  2016; Liotti & Gilbert, 2011; Panksepp, 1998; Tomasello et al., 
2005). . Cognitive and psychodynamic theories about human motivation concur (Baumeister & Leary, 
1995; Gilbert, 2005; Ivaldi, 2016; Liotti & Gilbert, 2011; Lichtenberg, 1989; Tomasello et al., 2005) 
indicating that several motives exist including attachment (Bowlby, 1969), social rank/competition, 
group inclusion/affiliation, caregiving, exploration/autonomy, sexuality and cooperation among 
peers. These motivational goals have emerged in order to increase the likelihood of survival and 
adaptation to an ecological niche. As a consequence, social or internal signals indicating that these 
goals will remain unmet can trigger distress to the individuals, regardless of the accuracy of the 
appraisal. If these negative appraisals become rigid over time, psychological distress becomes chronic 
leaving individuals impaired in the development effective strategies to adapt themselves to the social 
context (Cortina & Liotti, 2014). Therefore, helping individuals find avenues to meet such those goals 
should and make their attributions more complex and flexible, should reduce distress, increase hope 
and motivation, and enhance their capacity to form and sustain social bonds  
With regard to specific motivational goals attachment (Bowlby, 1969) is the need to find 
protection and cares in moments of distress by someone perceived as strong, safe and secure. Social 
rank is activated under limited resources and gives a hierarchical framework for access to those 
resources (Gilbert, 2005). When moved by this motive, individuals experience anger when they 
perceive someone is defying them or threatening their status, pride or despise when they feel superior, 
shame when feel the other is humiliating them and making them feel inferior, and sadness. Group 
inclusion/affiliation refers to the basic need to belong. Humans cannot live without a sense of being 
part of a larger community where they share value, interests, rites and goals. Caregiving complements 
attachment and is triggered by the perception that someone that is important to us and we consider in 
distress, danger or pain. The capacity for autonomous exploration of the environment is also 
important (Panksepp, 1998). Exploration denotes the ability to seek new resources in the environment 
and is triggered by curiosity. The sexual system regulates behaviours related to courting and seducing 
a possible romantic partner, with the goal of forming long-term bonds where primary sexual drives 
can be met and yield erotic pleasure. The cooperative system is fundamental for the formation of 
stable bonds and for the maintenance of cohesive groups (Tomasello et al., 2005). It aims at forming 
alliances and join resources to meet shared goals. Within the group-psychotherapy format outlined 
below we considered that providing participants in the programme with information about these 
motives that drive human behavior, and the emotions that are typically associated with these systems, 
would help them in making sense of what they and others experience when engaged in emotionally 
arousing social interactions.  
Metacognition  
Following from the above, one barrier to a healthy and adapted social life is poor 
metacognition -  that is the capacity to identify, reflect upon and master states of mind both of the self 
and of the others, as well as have the ability for reflection and mastery (Carcione et al., 2010; 2011; 
Dimaggio & Lysaker, 2015; Semerari et al., 2003; 2007). Individuals engage in metacognitive activity 
by identifying and understanding how we feel and what drives us to act;  and by forming an integrated 
view of ourselves, whilst holding various mental states that continuously alternate within ones’ mind. 
Individuals also use metacognitive skills when trying to understand how others are feeling and the 
intentions that are likely guiding their behavior. Lastly, metacognition includes the ability to use an 
understanding of mental states to manipulate and master them. For instance, mastery may be 
evidenced by manipulating conditions in which we calm down, concentrate or relax. Metacognition 
has been found to be impaired in the wide range of PDs and associated to symptoms and interpersonal 
difficulties (Lysaker et al., 2014; Maillard et al., 2017; Outcalt et al., 2016; Semerari et al., 2014) and 
appears as growing during successful treatments (Carcione et al., 2011; Dimaggio et al., 2009; 
Semerari et al., 2005). Overall, a knowledge of mental states is beneficial for the maintenance of 
relationships as it helps us foresee probable occurrences when we interact with others, solve any 
relational conflicts that may transpire, and achieve mutual relational goals. Metacognitive skills can 
fluctuate as the quality of relationships vary (Semerari et al., 2007). With a well-modulated emotional 
atmosphere and a cooperative relationship context aimed at pursuing common goals, a patient can 
have easier access to own thoughts and affects, and in parallel feel freer to consider different 
perspective when reasoning about what is passing through the mind of the other. However, there is a 
need to develop better evidence that metacognition improves in psychotherapy, and in particular in 
non-Borderline PD’s. To date, just one study analysed change in metacognition in a randomized trial 
for PD (Maillard et al., 2017). Results showed a marginal nonsignificant change in metacognition 
during 10-sessions of General Psychiatric Management for BPD, albeit with an improvement in basic 
abilities to use mental state awareness to effectively cope with symptoms  
 We also reasoned that young adults, once provided with psychoeducation about the main 
interpersonal motives and the associated cognitions and affects humans experience when driven by 
those, needed to practice mentalizing (Bateman & Fonagy, 2004) in the context of emotionally driven 
exchanges. Therefore MIT-G includes an experiential component, where individuals practice the 
ability to understand and regulate state of minds in the context of emotionally charged interactions. 
With such a richer knowledge ground, they could face with less distress and more success the 
demands of real life in the relevant life transitions they are facing.  
Metacognitive Interpersonal Therapy and the development of the group format. 
 To address problems in metacognition, in the context of struggling to reach for these basic, 
evolutionarily shaped motives, Metacognitive Interpersonal Therapy (MIT) was developed for the 
whole range of PDs (Dimaggio et al., 2007). Subsequent work has developed a series of formalized 
procedures within MIT to address these needs (Dimaggio et al., 2015). These include work aimed at 
forming a shared understanding of functioning, whereby clients are helped to develop an 
understanding of what they think and feel, and of how they are guided by maladaptive interpersonal 
schemas whilst striving to reach these goals. Furthermore, MIT fosters the client’s ability to take a 
critical distance from his/her maladaptive beliefs about the self and the others, together with an 
emphasis on access to healthy self-parts (e.g. self as lovable, active, committed, motivated, safe, 
curious, trustful, able to explore psychological states and so on). Clients are then invited to try new 
actions and to expand their meaning making repertoire and to pursue goals they feel that deeply 
belong to them to live a progressively more adapted and fulfilling life. MIT has been demonstrated 
to be effective in a single case series of patients with PD (Dimaggio et al., 2017) and results have 
been replicated in a multiple-baseline single case series (see Gordon-King, Schweitzer & Dimaggio, 
2017; in press).    
In order to meet the need to develop short-term group protocols, we designed a combined 
psychoeducational/experiential format of 16-sessions - MIT-Group (MIT-G). Here participants are 
first briefed about the existence of the above described interpersonal motives, and then are invited to 
narrate episodes related to these motives. These episodes are then role-played, to promote 
metacognition. With increased knowledge about mental states, participants can then search for more 
meaningful and adaptive solutions to their interpersonal difficulties. The idea is that, at least in part, 
the capacity to use mental states for purposeful problem solving can be trained. First, individuals need 
to know basic concepts about what happens in humans when engaged in the process of meeting 
evolutionarily shaped motives, and then should practice using mental states understanding in a 
protected environment, which is the therapy group. MIT and MIT-G together with its parallel 
application to psychosis (MOSST; Ottavi et al., 2014), are consistent with a suite of therapies aimed 
at improving awareness of mental states, including Metacognitive Reflection and Insight Therapy 
(MERIT; Lysaker & Klion, 2017; see Vohs & Leonhardt, 2016 for its application to PD) and 
metacognition oriented training (Moritz et al., 2011) or social cognitive training (Horan et al., 2018). 
There are significant similarities with MERIT (see Lysaker et al., 2011) as both approaches endorse 
the premise that metacognition needs to be improved in a context of subtle attention to the 
intersubjective process and that the  therapeutic goal is to achieve a richer and open-ended making of 
own life. However, MIT-G uniquely endorses evolutionary motivational theory and aims to first 
detecting, prior to changing maladaptive interpersonal patterns. MIT differs from metacognitive 
training (Moritz et al., 2011) and social cognitive training (Horan et al., 2018) as these therapies 
primarily focus on enhancing correct detection of cognitive biases and of emotions (rather than 
erroneous detection), whereas MIT seeks to promote flexible reasoning about mental states.  
Study aims and hypotheses 
In this feasibility study we aimed to address the acceptability and clinical effectiveness of 
MIT-G in a sample of patients diagnosed with mixed PD’s (mostly of the over-regulated type). Our 
primary hypothesis was that MIT-G would lead to reduction in symptoms and improved wellbeing 
and functioning compared with treatment as usual (TAU). Our secondary hypothesis was that MIT-
G would be associated with greater improvements in candidate mechanisms of change than TAU, 
specifically considering changes in metacognition, emotional awareness and emotional regulation.  
Methods 
Participants 
Twenty participants were assessed as eligible to participate, having met criteria for Avoidant, 
Dependent, Obsessive-Compulsive, Narcissistic, Paranoid, Passive-Aggressive and Depressive PD. 
Participants meeting PDNOS criteria (as diagnosed for meeting at least 10 criteria at SCID-II) were 
included, provided that criteria came from these and schizoid PD. Exclusion criteria were: Intellectual 
disability, organic brain disease or severe somatic disease impairing cerebral function, psychosis, 
bipolar I disorder or substance abuse severe enough to require specialized treatment. Antisocial and 
schizotypal PDs were also excluded. Patients hospitalized in the month before the beginning of the 
programme were excluded, as were patients with prominent emotional dysregulation, intense 
suicidality or physical aggression towards others. Patients who were unable to consent could not be 
included. In addition to meeting inclusion criteria, given that participants were recruited from an 
outpatient setting, patients had to have been referred for treatment of social or interpersonal problems 
e.g. difficulties in the vocational field, forming and sustaining romantic bonds and feeling excluded 
from groups.  
Design and procedures  
Psychologists and psychiatrists working in an Outpatient Mental Health Service in 
(BLINDED) were briefed about the study aims and goals. All patients referred to an outpatient facility 
for mental health in (BLINDED) between October and November 2015, and aged between 18 and 
25, and who potentially met inclusion criteria were referred for assessment. Participants meeting 
inclusion criteria were subsequently randomly allocated to one of two conditions (see Fig. 1): the 
MIT-G programme or waiting list control TAU. (which included consultations on medications and 
supportive counselling). Assessments of symptoms, functioning and psychological processes were 
conducted at baseline and repeated for both groups at conclusion of the group. Psychologists 
performing assessments were blind to treatment allocation and groups. Therapists were blinded to 
outcomes and process measures until after follow-up. Participants in the MIT-G were evaluated at a 
3-months follow-up. However, upon request of the ethics committee, participants in the waiting 
list+TAU arm had to begin MIT-G once both groups had completed assessment at termination, 
without waiting for the follow-up, so could not evaluated at the 3-months follow-up. The study was 
approved by the local ethics committee and all subjects gave written informed consent. Of 20 patients 
meeting inclusion criteria, 10 were randomized to each group. Given the characteristics of the study 
and the nature of the intervention, conducted in a public mental health outpatient facility, it was 
impossible to run a double-blind study. 
 
                                              INSERT FIGURE  1 ABOUT HERE 
 
 
 
Intervention  
The MIT-G programme comprised 16 sessions of two hours each. Every session had a fixed 
structure. Sessions were divided in blocks of 2 or 3 sessions for each specific motivational system. 
During the first session of each block each motivational system was described in simple language. 
Then a series of video clips were presented, taken from movies or cartoons, demonstrating situations 
where actors’ behavior was driven by the specific motive. This scaffolded the therapists’ description 
of typical triggers, shut offs and typical human experiences of each motivational drive. Systems were 
presented in the following order: 1) social rank/competition, 2) group inclusion/affiliation, 3) 
attachment, 4) caregiving, 5) exploration, 6) sexuality and 7) cooperation. After psychoeducation, 
therapists asked participants to write down a specific autobiographical memory where their actions 
were driven by that system. Therapists then selected one situation to be role-played. Across the 
programme all participants had to role-play at least one episode from their own life. The scene enacted 
was then replayed with the participant taking the part of the other. In the ensuing group discussion, 
the protagonist and all the group members were asked to reason about what kind of mental states the 
participants might have experienced and identify the verbal and nonverbal cues guiding this position. 
In the second session concerning the same motive, participants were asked to attempt a problem-
solving strategy during the role-play, on the basis of the mental states that they are experiencing and 
of the ones they ascribe to the others. In metacognitive terms, therefore, the second session (and the 
third in the case of  cooperative system), focused on mastery, that is the capacity to use information 
about mental states in order to reach own goals, solve conflicts and find and promote more fulfilling 
and cooperative relationships.  
During the 16th session the participants shared their experience of the programme and 
reviewed the process of change, including possible benefits and what the group brought to their life. 
They also discussed continuing problems and any issues arising concerning the programme itself.  
 
Therapists, training and supervision 
Two MIT-certified therapists, both clinical psychologists with 5 years of experience, led the 
group. Prior to starting MIT-G, therapists completed a 12-hour training programme with one of the 
two developers (BLINDED). During programme delivery, therapists were supervised for 1.5 hours 
per fortnight, in order to increase fidelity and adherence to the manual and to evaluate any clinical 
problems arising within the group. Therapists involved in MIT-G did not deliver any sessions or 
consultation to participants involved in the waiting-list+TAU group.  
 
Treatment as usual 
TAU consisted of weekly individual consultations with clinical psychologists of the Mental 
Health Service and were oriented to support participant’s emotional suffering. No interventions aimed 
at promoting metacognition or providing psychoeducation on motivational systems underlying social 
behaviour were included in the TAU condition. Psychiatric consultation was available if clinicians 
considered it necessary or if requested by the participant. 
  
Materials  
Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II; First, Spitzer, 
Gibbon, & Williams, 1997). This diagnostic interview was used to assess eligibility for the study and 
to identify PD psychopathology.  
 Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM): (Evans et al., 
2002) is a 34-item self-report questionnaire assessing problems and symptoms in four domains: 
subjective wellbeing, symptoms (anxiety, depression, somatic complaints, trauma-related); general, 
relational and social functioning, and risk (aggression towards self, e.g. suicidality, or towards others, 
e.g. aggression). The Italian version (Palmieri et al., 2009) has good psychometric properties, with 
internal consistency not differing significantly between clinical and non-clinical samples,  and all 
domains demonstrated α  0.7 - 0.9.  
Metacognition Assessment Scale-Abbreviated (MAS-A; Lysaker et al., 2005) is a rating scale, 
adapted from the MAS (Semerari et al., 2003) that assesses synthetic metacognitive capacities or the 
ability to synthesize discrete pieces of information into an integrated representation. This assessment 
is rated on the basis of the Indiana Interview for Psychiatric Illness (IPII, Lysaker et al., 2002) and 
produces four scores and a total score which is the sum of those four scores.  Self-reflectivity is a 9-
point scale that gauges one’s ability to form ideas about oneself in an increasingly plausible and 
integrated manner. Awareness of the Mind of the Other is a 7-point scale that assesses one’s ability 
to form ideas about others in an increasingly plausible and complex manner. Decentration is a 3-point 
scale that addresses one’s ability to form ideas about oneself and others within the context of the 
larger world. Mastery is a 9-point scale that assesses one’s capacity to use knowledge of oneself and 
others to respond to psychological and social challenges. For all four scales, higher scores indicate 
greater capacity for metacognition. The MAS-A has good inter-rater reliability with intra-class 
coefficients ranging from 0.71 to 0.91 (Lysaker at al., 2005). MAS-A scores have been associated 
with assessments of awareness of illness, complexity of social schemas, preferences for active coping, 
and cognitive insight (Lysaker et al., 2015).  
The Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004) is a self-report 
measure scoring on six dimensions of emotion dysregulation though we only used the total score 
here. The Italian version of the DERS (Giromini, Velotti, de Campora, Bonalume, & Zavattini, 2012) 
has good psychometric properties in both clinical and community samples. In the current study, 
internal consistency for the DERS total score was good (α = .89). 
The Toronto Alexithymia Scale – 20 (TAS-20; Bagby et al., 1994a) is a 20-item self-report 
measure of alexithymia. Items are rated using a five-point Likert scale, with participants indicating 
level of agreement with statements that assess both the affective and cognitive elements of the 
alexithymia construct. Total scores range from 20 to 100, with higher scores indicating greater degree 
of alexithymia. Scores exceeding 60 are indicative of clinically significant alexithymia. Evidence of 
acceptable internal consistency, test-retest reliability, and construct, concurrent, and convergent 
validity has been reported (Bagby et al., 1994a; 1994b). Internal consistency in the current study was  
α = .66. 
 
Statistical analyses 
Data were explored for normality and parametric or non-parametric statistics used 
accordingly. Baseline descriptive statistics and comparisons were reported for socio-demographic 
and clinical variables using independent samples t-tests for continuous variables and chi-squared 
tests for categorical variables. Comparisons between groups at follow-up were initially analysed 
using independent samples t-tests for group differences, with equal variances assumed where 
indicated. Univariate analyses of covariance were used to investigate changes between groups 
across time-points. Paired samples t-tests were used in the MIT-G group to ascertain whether there 
was a significant effect of treatment on outcomes between baseline, post-treatment and 3-month 
follow-up. Effect sizes were calculated using G Power 3.1.  
Results 
Demographics, Feasibility and Treatment Acceptability 
Demographic details are listed in Table 1. Participants were aged between 19 and 25 and were 
unmarried. There were no differences between the groups on demographic variables. The 20 
participants meeting inclusion criteria had the following diagnosis of PD (multiple PD diagnosis 
could be assigned): 11 Depressive PD, 6 Dependent PD, 6 Avoidant PD, 1 Narcissistic PD, 1 Paranoid 
PD, 4 PD NOS. Symptoms were assessed with the MINI International Neuropsychiatric Interview 
(Sheehan et al., 1998): 11 had Depressive disorders,  5 had Generalized Anxiety Disorder, 4 had panic 
attacks and 2 had social phobia.  
Of the 10 participants randomized to receive MIT-G, 8 completed treatment and  2 dropped-
out, one after 7 completed sessions and one after 9 completed sessions. One felt excluded from the 
group, the other could not further because his university schedule and group sessions did not match. 
Of the 8 completers, attendance was very good, participants completed on average >14 of the 16 
scheduled session (attendance rate=92.19%). Of note, the clients who dropped-out still completed 
half of the programme, confirming the good capacity of MIT-G to retain patients in treatment and 
engage them in the therapy process. Only one participant of MIT-G group received benzodiazepines 
for a short period during treatment, the others did not receive any medication. 
Changes in clinical variables across treatment are reported in Table 2. There were no 
differences between MIT-G and TAU at baseline on symptoms, PD symptoms or psychological 
variables. However, at post treatment assessment the MIT-G patients had significantly lower scores 
on the CORE-OM (Mean difference = -2.39, 95% CI=-7.41 to -0.79,   t=-2.6, df=18; p=.018; d=1.16).  
There were no significant post-treatment differences between groups on emotion dysregulation, or 
alexithymia, although effect sizes were of medium size. There was also a post-treatment group 
difference on self-related metacognition with MIT-G patients displaying significantly higher scores 
(Mean difference = 2.40, 95% CI = 1.16 to -3.64,   t=4.10, df=18; p=.001, d=1.82). There were no 
significant between group differences post treatment on other-related metacognition or decentration, 
although the difference in Mastery scores approached significance in favour of MIT-G (Mean 
difference = 1.13, 95% CI = -0.08 to 2.34,   t= 1.96, df = 18; p=.066, d=0.56). Effect sizes for within-
subject pre-post treatment changes indicated large effect size improvements (see Cohen’s d; Table 2) 
on CORE-OM, alexithymia, self-related metacognition, other-related metacognition, and mastery in 
the MIT group; and effect sizes of medium magnitude for emotional dysregulation and metacognitive 
decentration. In contrast, the only moderate magnitude within-subjects effect size change for TAU 
was on CORE-OM, with all other variables reporting small or negligible effect sizes for within-
subjects change on TAU.  
When baseline scores were included in the analyses, ANCOVAs indicated a significant effect 
of treatment on CORE-OM symptoms in favour of MIT-G (F(1,17) = 5.32, p <.034, pη2 = .24).  We 
also identified a significant effect of treatment on alexithymia scores in favour of MIT-G (F(1,15) = 
5.69, p <.0312, pη2 = .275),  but there was no difference between groups on DERS totals. With regard 
to metacognition, we observed significant improvements in the MIT-G arm on Self-related 
metacognition (F(1,17) = 21.65, p <.001, pη2 = .560), Decentration (F(1,17) = 5.74, p <0.28, pη2 = 
.252) and Mastery (F(1,17) = 9.07, p <.008, pη2 = .348), but not in Other-related metacognition.  
With regard to follow-up paired samples t-tests indicated that at 3-month follow-up the MIT-
G group had significantly lower CORE-OM scores than at baseline with a large magnitude of change 
(Mean difference = 12.0; SD = 6.60; 95%CI = 7.26 to 16.70; t=5.74; df = 9; p<0.001; d=1.93) and 
compared with post-treatment follow-up (Mean difference = 5.48; SD = 3.93; 95%CI = 2.67 to 8.28; 
t=4.41; df = 9; p=0.002; d=1.93). At 3-month follow-up the MIT-G group had significantly lower 
alexithymia scores than at baseline, with a large magnitude effect (Mean difference = 9.9; SD = 11.25, 
95%CI = 1.85 to 17.94; t=2.78; df = 9; p=0.021; d=0.87), but there were no significant differences 
from post-treatment to follow-up. There was no significant effect from baseline to 3-month follow-
up of MIT-G on emotion regulation scores, although the magnitude of change was consistent with a 
medium effect size (d=0.51).  
  
 
Discussion 
 Young adults with non-Borderline PDs, presenting with both interpersonal and social  
difficulties symptoms need structured and economical psychotherapies, with a focus on negotiating 
life transitions. We designed a short-term 16 session treatment programme, guided by motivational 
and metacognitive principles, with an aim to promote patient’s awareness of mental states, both of 
themselves and the others and use that awareness to first understand their problematic views of 
themselves and the others is mostly schema-driven and secondly to use the increased awareness in 
order to find more adaptive solution to their struggles.  
Therapists could be easily trained and participants’ compliance was high. Though we did not 
perform any formal qualitative analysis, it appeared that all completers reported in their post-
treatment interviews IIPIs having had positive experiences both in regard to outcomes and their 
experience of social contact with the other participants. Outcomes on symptoms and social 
functioning measures were positive with clear improvements in the MIT-G arm at therapy 
termination, with results sustained at follow-up. Effect sizes were of large magnitude, suggesting that 
MIT-G is useful in domains of interest for young individuals with PD. Unfortunately, our hypothesis 
that MIT-G could help improve emotion dysregulation was not sustained in our analyses though the 
statistical trend was towards improvement. It may have been the case that the small sample size 
inflated the likelihood of a Type II error . We note that, based on the magnitude of effect size, 
relatively modest increases in sample size should also give adequate power to identify significant 
change on the emotion dysregulation, alexithymia and metacognitive Mastery scales.  
The theoretical basis for MIT-G postulated that changes in functioning would be attributable 
in part to improvements in awareness of mental states and the capacity to use psychological 
understanding. Thus, metacognitive awareness and capacity would be the mechanism of changes 
underlying improvements in  social adjustment and capacity to cope with distress. Our results 
supported this idea, as many aspects of metacognition significantly increased from pre to post-
treatment with large effect sizes. This is the first time such an effect of metacognition is demonstrated 
in a controlled study of metacognition oriented therapies for PD and replicates similar outcomes in 
related therapies for psychosis such as MOSST (Ottavi et al., 2014; Inchausti et al., 2017). Patients 
in the MIT-G arm became more aware of their mental states and begun to take a critical stance towards 
their own evaluations of social interactions, so able to question their maladaptive assumptions that, 
for example they were inept or inadequate. In parallel they were better able to grasp that the 
perspective of the other is different than their own. This is not surprising, as theory (Dimaggio et al., 
2008) and evidence from single case studies (Lysaker et al., 2007) suggests that developing a richer 
understanding of one’s own mind is necessary for acquisition of an increased capacity to understand 
others mental states. It is also possible that participants used the perspective of the others in the group 
to first gain a richer understanding of their own wishes, preferences and problems and started 
questioning their rigid beliefs about self and others. This came together with realizing that others see 
the world differently than the individual does (Semerari et al., 2014), though they gained only a 
marginally richer understanding of the complexities of the mind of the others. Finally, participants 
capacity to use mentalistic information to inform purposeful problem solving grew over the course 
of treatment. This was a stated goal of the MIT-G, as the programme included role-plays aimed at 
solving relationally challenging situations via deeper awareness of mental states. Improvements in 
the capacity to understand mental states were also evident through clinically significant reductions in 
alexithymia: as participants become more able to find emotional words to describe their inner 
experiences. These results are consistent with previous non-controlled studies demonstrating that 
metacognition grows in successful therapies for PD (Carcione et al., 2011; Dimaggio et al., 2009; 
Semerari et al., 2005). Our results also correspond with gains in metacognition observed during a 
randomized trial for BPD (Maillard et al., 2017), although the effect in the current study is of larger 
magnitude. The difference in magnitude of change between the two studies may in part be attributable 
to differences in presentation, with our non-BPD group perhaps having a less dysfunctional pattern 
of emotion regulation, with correspondingly greater capacity to rapidly engage with the metacognitive 
aspects of the treatment approach. Results are also consistent with findings using other instruments 
that demonstrate increased capacity to reflect on mental states via psychotherapeutic intervention 
(Fisher-Kern et al., 2015; Levy et al., 2006). Going forward our intention would be to explore whether 
metacognition predicts change, potentially via advanced techniques such as mixed effect modelling. 
This statistical approach has yielded promising demonstrations of the effectiveness of EBPI’s in small 
samples in other complex mental health problems (Foster et al., 2010).  
As a feasibility study we acknowledge a number of limitations. First the sample size was 
small, although effect sizes were large. Consequently, there is a need for replication with larger 
samples. Second, we acknowledge that we did not have a repeated measures baseline assessment 
prior to treatment, instead relying on pre-post changes. This could be addressed in a further trial. 
Third, assessment of change in the interpersonal domain need to be assessed with other measures in 
order to understand if the appraisal of self and others changed, e.g. inventories of interpersonal 
problems or of maladaptive schemas. Fourth, amongst the targeted PD, Obsessive-Compulsive was 
not present, while only one patient had Narcissistic or Paranoid PD. Results therefore cannot be 
generalized to these PDs. Fifth, clients were Caucasian young adults in an outpatient clinical setting 
so results may not generalize to other ethnicities, or other healthcare systems. Sixth, we note that use 
of TAU waitlist control group introduces an expectation bias around  the prospect of future treatment, 
which may have impacted on our findings. Seventh, due to power issues we did not perform mediation 
analyses on mechanisms of change, instead simply noting whether improvement in these mechanisms 
occurred. Finally, we also note that change was in part measured using self-report measures of 
function (CORE-OM), therefore it would be useful for future studies to assess change on interview 
based measures of outcome.  
With regard to next steps, future studies may evaluate if both the psychoeducational and 
experiential part are necessary and potentially identify what their differential contribution is to 
therapy outcomes. This could be achieved by using brief session-by-session monitoring. There is also 
the need to see if MIT-G is effective also with older individuals. Mechanisms of change must be 
investigated, in order to understand which mediating factors were implicated, with a possible role for 
improvements in metacognition. The role of therapeutic alliance also needs to be explored. Future 
studies may also investigate cost-effectiveness of MIT-G, as has been implemented in other EBPI 
studies of BPD (e.g. van Asselt et al., 2008) and also with regard to indirect cost implications of 
health service usage in  non-Borderline PD’s ( Tyrer et al. 2013). 
In summary, results support former empirical findings from single-case series that MIT can 
be effective for PD (Dimaggio et al., 2017; Gordon-King et al., 2018). Providing young adults with 
mixed non-Borderline PDs with information about the main interpersonal motives, the mental states 
individuals experience when a specific domain is triggered, and then facilitating practice of awareness 
and regulation of mental states in a group format is safe, well-accepted and yields significant clinical 
change which is sustained over time. We propose that the findings strongly support further 
investigation of MIT-G for PD as a promising short-term and effective method to ameliorate 
symptoms and improve social functioning. We hope that future and larger studies will evaluate 
whether change is sustained over time. Future research can also identify how many individuals 
continue to move towards wellness and adaptation without further treatment and identify who, and 
for what reasons, will require more treatment in order to maximize therapeutic change. 
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Table 1: Participant demographics and diagnostics 
 MIT-G (n=10) TAU (N=10) 
Mean age (S.D.) 21.3 (.68) 21.8 (2.04) 
Gender Female (n) 5 4 
Highest Education Level 
Middle School 2 4 
Upper Secondary School 8 6 
Occupation 
Unemployed 2 6 
Employed  3 0 
Student 5 4 
Notes: S.D. = Standard Deviation. MIT-G = Metacognitive Interpersonal Therapy – Group Format; 
TAU = Treatment As Usual; 
 
Table 2: Changes in symptoms and functioning across timepoints 
Measure Baseline Post-Treatment 3-month 
Follow-
up 
Within-group 
effect size 
baseline-post 
treatment 
Within-group 
effect size 
baseline – 3 
month follow-up  
Between-group 
post-treatment 
effect size at post-
treatment  
 
 MIT-G TAU MIT-G TAU MIT-G MIT-G TAU MIT-G MIT-G vs TAU 
 Mean 
(S.D.) 
Mean (S.D.) Mean 
(S.D.) 
Mean 
(S.D.) 
Mean 
(S.D.) 
d d d d Post Hoc Power 
CORE-OM 
Total 
12.85 
(4.60) 
15.24 (6.68) 7.68 
(1.94)* 
11.78 
(4.59) 
2.20 
(2.67) 
1.14 0.64 1.93 1.16 0.80 
DERS Total 95 
(16.19) 
100.9(17.67) 76.40 
(26.78) 
97.11 
(29.17) 
87.00 
(20.01) 
0.74 0.16 0.51 0.73 0.47 
TAS-Total 54.20 
(11.52) 
51.5 (10.99) 43.50 
(11.70) 
52.63 
(12.59) 
44.30 
(11.79) 
1.11 0.10 0.87 0.75 0.49 
Metacognition 
Self2 
4.3 
(1.32) 
4.1 (0.97) 5.75 
(1.36)* 
3.35 
(1.27) 
- 1.73 0.56 - 1.82 0.98 
Metacognition 
Others2 
2.10 
(0.52) 
2.85 (1.31) 2.90 
(1.07) 
3.30 
(0.67) 
- 0.99 0.32 - 0.44 0.24 
Metacognition 
Decentration2 
0.75 
(0.75) 
1.15 (1.03) 1.15 
(1.03) 
0.70 
(0.48) 
- 0.59 0.51 - 0.56 0.33 
Metacognition 
Mastery2 
2.90 
(1.07) 
3.30 (0.67) 4.18 
(1.35) 
3.05 
(1.23) 
- 1.51 0.20 - 0.85 0.57 
Notes: CORE-OM Total = Clinical Outcomes in Routine Evaluation Outcome Measure Total Score; DERS Total = Difficulties in Emotion 
Regulation Scale; TAS-Total = Toronto Alexithymia Scale Total Score; Metacognition Self = Metacognition Assessment Scale, Self-related Scale; 
Metacognition Others = Metacognition Assessment Scale, Other-related Scale; Metacognition Decentration = Metacognition Assessment Scale, 
Decentration Scale; Metacognition Mastery = Metacognition Assessment Scale, Mastery Scale; S.D. = Standard Deviation. d= Effect Size in 
Cohen’s D;  MIT-G = Metacognitive Interpersonal Therapy – Group Format; TAU = Treatment As Usual; * = significant difference between 
groups of p<.05; 1 n=8; 2 within-subjects effect sizes not available for follow-up data.  
 
